EyePoint Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of EYPT for the last quarter is 10.52 M USD, and it's 11.05% higher compared to the previous quarter. The net income of Q3 24 is -29.36 M USD.